Switzerland temporarily halts Ebola vaccine testing
The clinical trial of an Ebola vaccine in Switzerland has been interrupted after some patients complained of joint pains in their hands and feet.
The University of Geneva Hospital said the trial was stopped one week early in all 59 volunteers as a precautionary measure.
The side-effects were reportedly experienced by four volunteers.
The hospital said human safety trials would resume on January 5, next year, in up to 15 volunteers after checks have taken place to ensure the joint pain symptoms are benign and temporary.
There is currently no vaccine licensed for use to protect against Ebola.
Two vaccines are currently being tested in humans in a number of countries.
Follow us on Twitter:
Follow us on Instagram:
Watch our videos on YouTube:
Email us: firstname.lastname@example.org